De-Chong Zheng

456 total citations
10 papers, 334 citations indexed

About

De-Chong Zheng is a scholar working on Molecular Biology, Plant Science and Rheumatology. According to data from OpenAlex, De-Chong Zheng has authored 10 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Plant Science and 3 papers in Rheumatology. Recurrent topics in De-Chong Zheng's work include Bioactive Compounds in Plants (3 papers), Phytochemicals and Antioxidant Activities (2 papers) and Systemic Lupus Erythematosus Research (2 papers). De-Chong Zheng is often cited by papers focused on Bioactive Compounds in Plants (3 papers), Phytochemicals and Antioxidant Activities (2 papers) and Systemic Lupus Erythematosus Research (2 papers). De-Chong Zheng collaborates with scholars based in China, Macao and United States. De-Chong Zheng's co-authors include Xiaoqian Wu, Zumei Liu, Ying Xie, Jiandong Luo, You Zhou, Senling Feng, Hua Zhou, Chu-Tian Mai, Xinyi Cheng and Qing Xiao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Molecular and Cellular Cardiology and Pharmacological Research.

In The Last Decade

De-Chong Zheng

10 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
De-Chong Zheng China	8	163	61	53	44	41	10	334
Ruimin Wang China	13	151 0.9×	44 0.7×	58 1.1×	41 0.9×	46 1.1×	49	503
Annamaria Tavernese Italy	14	174 1.1×	44 0.7×	76 1.4×	45 1.0×	51 1.2×	40	509
Vladimíra Mondočková Slovakia	11	171 1.0×	50 0.8×	27 0.5×	51 1.2×	59 1.4×	23	515
Nagwa Ahmed Egypt	11	136 0.8×	39 0.6×	49 0.9×	30 0.7×	41 1.0×	27	464
Ying‐Kai Hong China	12	172 1.1×	94 1.5×	34 0.6×	46 1.0×	18 0.4×	20	510
Franco Romeo Italy	7	132 0.8×	59 1.0×	66 1.2×	26 0.6×	72 1.8×	7	482
Wen Cao China	10	162 1.0×	44 0.7×	36 0.7×	21 0.5×	27 0.7×	21	370
Tae‐Young Oh South Korea	10	156 1.0×	65 1.1×	35 0.7×	21 0.5×	38 0.9×	18	423
Hanaa I. Fahim Egypt	11	117 0.7×	65 1.1×	27 0.5×	22 0.5×	49 1.2×	18	345
Wenjing Li China	11	176 1.1×	37 0.6×	42 0.8×	22 0.5×	34 0.8×	47	471

Countries citing papers authored by De-Chong Zheng

Since Specialization

Citations

This map shows the geographic impact of De-Chong Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De-Chong Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De-Chong Zheng more than expected).

Fields of papers citing papers by De-Chong Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De-Chong Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De-Chong Zheng. The network helps show where De-Chong Zheng may publish in the future.

Co-authorship network of co-authors of De-Chong Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of De-Chong Zheng. A scholar is included among the top collaborators of De-Chong Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De-Chong Zheng. De-Chong Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zheng, De-Chong, et al.. (2024). Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming. Pharmacological Research. 209. 107407–107407. 7 indexed citations

Zheng, De-Chong, et al.. (2024). Liver X receptor inverse agonist SR9243 attenuates rheumatoid arthritis via modulating glycolytic metabolism of macrophages. Acta Pharmacologica Sinica. 45(11). 2354–2365. 8 indexed citations

Xie, Ying, Chu-Tian Mai, De-Chong Zheng, et al.. (2021). Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine. Phytomedicine. 85. 153522–153522. 50 indexed citations

Liu, Zumei, et al.. (2021). Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation. Pharmacology Research & Perspectives. 9(2). e00728–e00728. 19 indexed citations

Wang, Xiaolin, De-Chong Zheng, Chu-Tian Mai, et al.. (2021). Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system. Acta Pharmacologica Sinica. 43(8). 2094–2108. 16 indexed citations

Mai, Chu-Tian, De-Chong Zheng, Xinzhi Li, Hua Zhou, & Ying Xie. (2021). Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis. Pharmacological Research. 170. 105747–105747. 6 indexed citations

Zheng, De-Chong, Zumei Liu, You Zhou, et al.. (2020). Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway. Pharmacological Research. 153. 104655–104655. 102 indexed citations

Feng, Senling, Deyan Wu, De-Chong Zheng, et al.. (2019). Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents. Acta Pharmaceutica Sinica B. 10(2). 327–343. 48 indexed citations

Wu, Xiaoqian, Xiaoyan Zhu, Dajun Liu, et al.. (2018). Increased expression of DRAM1 confers myocardial protection against ischemia via restoring autophagy flux. Journal of Molecular and Cellular Cardiology. 124. 70–82. 30 indexed citations

10.

Wu, Xiaoqian, et al.. (2017). Nobiletin attenuates adverse cardiac remodeling after acute myocardial infarction in rats via restoring autophagy flux. Biochemical and Biophysical Research Communications. 492(2). 262–268. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact